Find My Journal

Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Yu‐Pei Chen, Xu Liu, Qin Zhou, Kunyu Yang, Feng Jin, Xiaodong Zhu, Mei Shi, Guoqing Hu, Wei‐Han Hu, Yan Sun, Hong-Fen Wu, Hui Wu, Qin Lin, Hui Wang, Ye Tian, Ning Zhang, Xicheng Wang, Liangfang Shen, Zhengzheng Liu, Jing Huang, Xiuling Luo, Ling Li, Jian Zang, Qi Mei, Baomin Zheng, Dan Yue, Jing Xu, San‐Gang Wu, Yanxia Shi, Yan‐Ping Mao, Lei Chen, Wen‐Fei Li, Guan‐Qun Zhou, Rui Sun, Rui Guo, Yuan Zhang, Cheng Xu, Jia‐Wei Lv, Ying Guo, Huixia Feng, Ling‐Long Tang, Fang‐Yun Xie, Ying Sun, Jun Ma

The Lancet, 2021

Sun Yat-sen University Cancer Center, Sun Yat-sen University, Central South University, Xiangya Hospital Central South University, Huazhong University of Science and Technology, Union Hospital, Affiliated Hospital of Guizhou Medical University, Guiyang Medical University, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, Xi'an Medical University, Air Force Medical University, Tongji Hospital, Peking University, Peking University Cancer Hospital, Zhengzhou University, Jilin Province Tumor Hospital, Henan Cancer Hospital, First Affiliated Hospital of Xiamen University, Hunan Cancer Hospital, Soochow University, Second Affiliated Hospital of Soochow University, First People's Hospital of Foshan, First Affiliated Hospital of Guangdong Pharmaceutical University

Publisher Website

Abstract

An abstract is not available for this record. Please visit the publisher website for more details.

228

Citations

View on Google Scholar